RT @Office_j: 【雑記】多発性骨髄腫例に対するDOACの出血・VTEリスクをプラセボと比較するRCT “NCT02958969” [https://t.co/AHHhhVoEIy] が終了。 https://t.co/hn6mS8JZxR https://t.c…
976 followers
4,423 followers
【雑記】多発性骨髄腫例に対するDOACの出血・VTEリスクをプラセボと比較するRCT “NCT02958969” [https://t.co/AHHhhVoEIy] が終了。 https://t.co/hn6mS8JZxR https://t.co/pVDDWpCYVF
349 followers
RT @CardioOncology: Great article by @myeloma_doc_com on safety of DOAC in multiple myeloma patients at high risk of thrombosis. Vascular D…
7,925 followers
Great article by @myeloma_doc_com on safety of DOAC in multiple myeloma patients at high risk of thrombosis. Vascular Dz is a new frontier in #CardioOnc Will be a major focus of @VUMC_heart #CardioOnc program & AHA committee for coming year! @AHAScienc